Stay updated on Arimoclomol in Myositis-Open Label Extension Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.

Latest updates to the Arimoclomol in Myositis-Open Label Extension Clinical Trial page
- Check5 days agoChange DetectedAdded a new revision entry (v3.3.3) to the record history. Removed the HHS Vulnerability Disclosure link and the older revision entry v3.3.2.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedA new site revision entry v3.3.2 appears in the history, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedA new revision entry (v3.3.1) was added to the record history. An older revision (v3.2.0) was removed.SummaryDifference0.1%

- Check41 days agoChange DetectedA government funding lapse notice at the top of the page was removed; the rest of the study record page remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check55 days agoChange DetectedThe new screenshot shows the same record history page with identical version entries and no visible updates to the trial's core details (status, description, or eligibility). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference11%

Stay in the know with updates to Arimoclomol in Myositis-Open Label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.